Scarica l'app Stockscreener
0.00
100.00%
-3.20
Dopo l'orario di chiusura:
3.17
3.17
+
OncoCyte Corporation Borsa (OCX) Ultime notizie
Can OncoCyte Corporation hit a new high this monthStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
What momentum shifts mean for OncoCyte Corporation2025 Top Gainers & Community Verified Trade Signals - Newser
What indicators show strength in OncoCyte Corporation2025 Buyback Activity & Safe Capital Growth Stock Tips - Newser
What makes OncoCyte Corporation stock price move sharplyCEO Change & Consistent Income Trade Recommendations - thegnnews.com
Advanced analytics toolkit walkthrough for OncoCyte CorporationJuly 2025 Pullbacks & Safe Capital Growth Stock Tips - Newser
Is OncoCyte Corporation trending in predictive chart modelsQuarterly Profit Report & Technical Entry and Exit Tips - Newser
What technical models suggest about OncoCyte Corporation’s comebackEarnings Growth Report & Reliable Volume Spike Trade Alerts - Newser
OncoCyte Corporation’s volatility index tracking explainedTrade Exit Report & Fast Exit Strategy with Risk Control - Newser
OncoCyte Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingMarket Volume Summary & AI Enhanced Trading Signals - Newser
Detecting support and resistance levels for OncoCyte Corporation2025 Buyback Activity & Expert Approved Trade Ideas - Newser
Published on: 2025-08-15 03:47:40 - newsyoung.net
Will OncoCyte Corporation benefit from macro trendsWeekly Trade Analysis & Low Drawdown Momentum Ideas - Newser
What MACD signals say about OncoCyte Corporation2025 Analyst Calls & Detailed Earnings Play Strategies - Newser
Will a bounce in OncoCyte Corporation offer an exitTake Profit & Weekly High Return Forecasts - Newser
Is OncoCyte Corporation reversing from oversold territoryAnalyst Upgrade & Momentum Based Trading Signals - Newser
How to build a dashboard for OncoCyte Corporation stock2025 Market Trends & Weekly Market Pulse Updates - Newser
OncoCyte Corporation (NASDAQ:OCX) Q4 2024 Earnings Call Transcript - MSN
OncoCyte Corporation Crosses 200 Day MA — Signal or NoiseWeekly Profit Analysis & Verified Swing Trading Watchlist - 선데이타임즈
Using Bollinger Bands to evaluate OncoCyte CorporationJuly 2025 Selloffs & Weekly Momentum Picks - Newser
Statistical indicators supporting OncoCyte Corporation’s strengthWeekly Stock Analysis & Daily Entry Point Trade Alerts - Newser
Can OncoCyte Corporation recover in the next quarter2025 Market Outlook & Capital Efficient Trade Techniques - Newser
Reversal indicators forming on OncoCyte Corporation stockChart-Based Entry Confirmation for Beginners - Newser
Why OncoCyte Corporation stock attracts strong analyst attentionStable Swing Setup with Safety Analysis - Newser
Is OncoCyte Corporation stock overhyped or has real potentialTechnical Long-Term Outlook and Recap Guide - Newser
Combining machine learning predictions for OncoCyte CorporationExpert-Backed High Yield Stock Watchlist - Newser
Top chart patterns to watch in OncoCyte CorporationEarly Buy Opportunity with Chart Triggers - Newser
What MACD and RSI say about OncoCyte CorporationScalable Strategy with Chart Confirmation - Newser
Using economic indicators to assess OncoCyte Corporation potentialFree Accurate Technical Trend Reversal Picks - Newser
Using data filters to optimize entry into Amgen Inc.Entry Optimization Tool with Screener Logic - Newser
Best Momentum Stocks to Buy for May 6th - The Globe and Mail
How OncoCyte Corporation stock performs during market volatilityWeekly Entry Signal Based Forecast Tool - Newser
Is It Too Late to Sell OncoCyte CorporationConservative Long Term Growth Plans Under Review - beatles.ru
What to expect from OncoCyte Corporation in the next 30 daysMomentum Entry Alerts with Risk Control - Newser
Is OncoCyte Corporation building a consolidation baseAI-Powered Stock Trend Movement Analysis - Newser
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):